Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohan Hazra

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2010
Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte valueRicardo Oliveira, Margot Krauss, Suzanne Essama-Bibi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2020
Impact of Low Birth Weight and Prematurity on Neonatal Raltegravir Pharmacokinetics: Impaact P1097Diana F Clarke, Jos Lommerse, Edward P Acosta, et al.
The Pediatric Infectious Disease Journal|February 12, 2009
Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacyEllen Gould Chadwick, Jorge Pinto, Ram Yogev, et al.
AIDS (London, England)|July 24, 2019
Association between zidovudine-containing antiretroviral therapy exposure in utero and leukocyte telomere length at birthYoujin Wang, Sean S Brummel, Erin Beilstein-Wedel, et al.
AIDS (London, England)|March 3, 2012
Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infantsGeorge K Siberry, Paige L Williams, Hermann Mendez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 30, 2016
Association of Dyslipidemia and Glucose Abnormalities With Antiretroviral Treatment in a Cohort of HIV-Infected Latin American ChildrenMachline P Paganella, Rachel A Cohen, Donald R Harris, et al.
AIDS (London, England)|October 4, 2012
Bone mineral density in children and adolescents with perinatal HIV infectionLinda A DiMeglio, JiaJia Wang, George K Siberry, et al.
AIDS Care|June 28, 2011
Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposureKathleen M Malee, Katherine Tassiopoulos, Yanling Huo, et al.
AIDS (London, England)|October 23, 2013
Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatmentPaige L Williams, Mark J Abzug, Denise L Jacobson, et al.
BMJ Open|June 12, 2016
Following young people with perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP Up, a prospective cohort studyKatherine Tassiopoulos, Kunjal Patel, Julie Alperen, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2010
Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte valueRicardo Oliveira, Margot Krauss, Suzanne Essama-Bibi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2020
Impact of Low Birth Weight and Prematurity on Neonatal Raltegravir Pharmacokinetics: Impaact P1097Diana F Clarke, Jos Lommerse, Edward P Acosta, et al.
The Pediatric Infectious Disease Journal|February 12, 2009
Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacyEllen Gould Chadwick, Jorge Pinto, Ram Yogev, et al.
AIDS (London, England)|July 24, 2019
Association between zidovudine-containing antiretroviral therapy exposure in utero and leukocyte telomere length at birthYoujin Wang, Sean S Brummel, Erin Beilstein-Wedel, et al.
AIDS (London, England)|March 3, 2012
Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infantsGeorge K Siberry, Paige L Williams, Hermann Mendez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 30, 2016
Association of Dyslipidemia and Glucose Abnormalities With Antiretroviral Treatment in a Cohort of HIV-Infected Latin American ChildrenMachline P Paganella, Rachel A Cohen, Donald R Harris, et al.
AIDS (London, England)|October 4, 2012
Bone mineral density in children and adolescents with perinatal HIV infectionLinda A DiMeglio, JiaJia Wang, George K Siberry, et al.
AIDS Care|June 28, 2011
Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposureKathleen M Malee, Katherine Tassiopoulos, Yanling Huo, et al.
AIDS (London, England)|October 23, 2013
Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatmentPaige L Williams, Mark J Abzug, Denise L Jacobson, et al.
BMJ Open|June 12, 2016
Following young people with perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP Up, a prospective cohort studyKatherine Tassiopoulos, Kunjal Patel, Julie Alperen, et al.
Pageof 15